Growth In The Nocturia Market Driven By Rising Cardiovascular Disease Prevalence Influencing Market Expansion

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Nocturia Market During 2026–2030?

The nocturia market has shown substantial expansion in recent years. Its value is projected to increase from $3.1 billion in 2025 to $3.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.0%. This growth observed in past periods is largely a result of elements such as aging population growth, an increased incidence of benign prostatic hyperplasia, the rising prevalence of urinary tract infections, the widespread use of diuretic medications, and limited early diagnostic awareness.

The nocturia market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $4.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This projected growth during the forecast period is driven by factors such as an increasing demand for tailored treatment approaches, the broadening of home care therapies, a rise in healthcare spending, a greater emphasis on managing sleep quality, and enhanced accessibility to urology specialists. Key developments expected during this period encompass an expanding elderly population and associated urological conditions, a surge in the incidence of diabetes and metabolic disorders, heightened awareness and diagnostic efforts for lower urinary tract symptoms, a move towards combination drug regimens, and the wider adoption of home-based nocturia management solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21232&type=smp

What Key Drivers Are Fueling The Growth Of The Nocturia Market?

The expansion of the nocturia market is anticipated to be driven by the increasing incidence of cardiovascular ailments. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as stroke, hypertension, and heart disease. Factors contributing to the widespread occurrence of CVDs include an aging global population, inactive lifestyles, poor dietary habits, smoking, significant alcohol intake, obesity, elevated blood pressure and cholesterol, diabetes, and genetic predispositions. Individuals suffering from cardiovascular conditions frequently exhibit nocturia as a symptom, which in turn boosts the demand for diagnostic and therapeutic options. Given the global increase in cardiovascular issues, fueled by an aging populace and unhealthy habits, the necessity for efficient nocturia management will intensify. For example, data from September 2025, supplied by the British Heart Foundation, a UK-based charity, indicates that more than 7.6 million people in the UK—specifically over 4 million men and more than 3.6 million women—are currently affected by cardiovascular disease. Forecasts suggest that this figure could increase by approximately 1 million by 2030 and by roughly 2 million by 2040, primarily due to an aging population and enhanced survival rates. Consequently, the increasing prevalence of cardiovascular diseases is a key driver for the expansion of the nocturia market.

What Are The Key Segment Divisions In The Nocturia Market Segment Structure?

The nocturia market covered in this report is segmented –

1) By Drug: Anticholinergic Drugs, Desmopressin, Antibiotics, Antispasmodic, Other Drugs

2) By Indication: Mixed Nocturia, Low Nocturnal Bladder Capacity, Nocturnal Polyuria, Global Polyuria

3) By Causes: Urological Infection, Tumor Of The Bladder, Diuretic Medications, Regular Alcohol Or Coffee, Liver Infection, Diabetes, Pregnancy, Other Causes

4) By End User: Hospitals, Home Care, Clinics

Subsegments:

1) By Anticholinergic Drugs: Oxybutynin, Tolterodine, Solifenacin, Darifenacin, Fesoterodine

2) By Desmopressin: Intranasal Desmopressin, Oral Desmopressin

3) By Antibiotics: Nitrofurantoin, Trimethoprim, Fosfomycin

4) By Antispasmodic: Hyoscine Butylbromide, Flavoxate

5) By Other Drugs: Alpha-Blockers, Beta-3 Agonists

What Trends Are Influencing The Nocturia Market?

Major companies operating in the nocturia market are actively focusing on developing innovative products, such as orally disintegrating tablets, to enhance patient convenience and compliance. Orally disintegrating tablets (ODTs) are solid dosage forms designed to quickly dissolve in the mouth without the need for water, making them particularly suitable for patients who experience difficulty swallowing. As an illustration, in July 2024, Adalvo Limited, a Malta-based pharmaceutical company, introduced Desmopressin ODT in Europe for the treatment of conditions that lead to the body losing an excessive amount of fluid, such as central cranial diabetes insipidus. This synthetic form of vasopressin tablet is used to treat diabetes insipidus, excessive thirst and urination, and bedwetting by mimicking the natural hormone and limiting the quantity of water eliminated in urine. Additionally, it is employed to manage bleeding in mild to moderate hemophilia A and von Willebrand disease by promoting the release of blood clotting factors.

Which Organizations Are Engaged In The Nocturia Market?

Major companies operating in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc

Get The Full Nocturia Market Report:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Which Region Is The Leading Market For The Nocturia Market?

North America was the largest region in the nocturia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nocturia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Nocturia Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/nocturia-global-market-report

Browse Through More Reports Similar to the Global Nocturia Market 2026, By The Business Research Company

Retinal Disorder Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report

Night Vision Devices Market Report

https://www.thebusinessresearchcompany.com/report/night-vision-devices-global-market-report

Optic Nerve Disorders Treatment Market Report

https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795